(Q33457264)

26 July 2017

Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors (English)

1 reference

26 July 2017

0 references

1 reference

6

Olav Dahl

1 reference

26 July 2017

1

Anne Gry Bentzen

1 reference

26 July 2017

2

Lise Balteskard

1 reference

PubMed ID

23438358

26 July 2017

Marianne Grønlie Guren

series ordinal

7

object named as

Marianne Grønlie Guren

1 reference

26 July 2017

4

Gunilla Frykholm

1 reference

26 July 2017

3

Eva Hoff Wanderås

1 reference

26 July 2017

Tom Wilsgaard

5

1 reference

26 July 2017

26 February 2013

1 reference

26 July 2017

1 reference

26 July 2017

52

1 reference

26 July 2017

4

1 reference

26 July 2017

736-744

1 reference

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

26 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Long-term quality of life after radiotherapy for the treatment of anal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Interpreting the significance of changes in health-related quality-of-life scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Symptom burden in cancer survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

The perspective of the patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

"Pelvic radiation disease": new understanding and new solutions for a new disease in the era of cancer survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Sexual function in females after radiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Sexual function in males after radiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Late side effects and quality of life after radiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Integrating response shift into health-related quality of life research: a theoretical model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

The Oslo Health Study: The impact of self-selection in a large, population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770599

10.3109/0284186X.2013.770599

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

23438358